Rapports

Generics in South Africa

Rapport
Titre
Generics in South Africa
332.50EUR
Langue
English
Pages
36
Secteur
Santé
Date
Janvier 2016
Pays
Afrique du Sud
Type de Produit
Company report
Description du rapport

Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

- The South African generics market is exp

Table des matières

TABLE OF CONTENTS

Executive Summary 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market volume 10

Market Segmentation 11

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Market volume forecast 13

Five Forces Analysis 14

Summary 14

Buyer power 15

Supplier power 16

New entrants 17

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Adcock Ingram Holdings Limited 20

Aspen Pharmacare Holdings Ltd 24

Teva Pharmaceutical Industries Limited 28

Macroeconomic Indicators 31

Country Data 31

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35

List of Tables

Table 1: South Africa generics market value: $ million, 2011-15(e)

Table 2: South Africa generics market volume: % of total pharma volume, 2011-15(e)

Table 3: South Africa generics market geography segmentation: $ billion, 2015(e)

Table 4: South Africa generics market value forecast: $ million, 2015-20

Table 5: South Africa generics market volume forecast: % of total pharma volume, 2015-20

Table 6: Adcock Ingram Holdings Limited: key facts

Table 7: Adcock Ingram Holdings Limited: key financials ($)

Table 8: Adcock Ingram Holdings Limited: key financials (ZAR)

Table 9: Adcock Ingram Holdings Limited: key financial ratios

Table 10: Aspen Pharmacare Holdings Ltd: key facts

Table 11: Aspen Pharmacare Holdings Ltd: key financials ($)

Table 12: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 13: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 14: Teva Pharmaceutical Industries Limited: key facts

Table 15: Teva Pharmaceutical Industries Limited: key financials ($)

Table 16: Teva Pharmaceutical Industries Limited: key financial ratios

Table 17: South Africa size of population (million), 2011-15

Table 18: South Africa gdp (constant 2005 prices, $ billion), 2011-15

Table 19: South Africa gdp (current prices, $ billion), 2011-15

Table 20: South Africa inflation, 2011-15

Table 21: South Africa consumer price index (absolute), 2011-15

Table 22: South Africa exchange rate, 2011-15

List of Figures

Figure 1: South Africa generics market value: $ million, 2011-15(e)

Figure 2: South Africa generics market volume: % of total pharma volume, 2011-15(e)

Figure 3: South Africa generics market geography segmentation: % share, by value, 2015(e)

Figure 4: South Africa generics market value forecast: $ million, 2015-20

Figure 5: South Africa generics market volume forecast: % of total pharma volume, 2015-20

Figure 6: Forces driving competition in the generics market in South Africa, 2015

Figure 7: Drivers of buyer power in the generics market in South Africa, 2015

Figure 8: Drivers of supplier power in the generics market in South Africa, 2015

Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2015

Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2015

Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2015

Figure 12: Adcock Ingram Holdings Limited: revenues and profitability

Figure 13: Adcock Ingram Holdings Limited: assets and liabilities

Figure 14: Aspen Pharmacare Holdings Ltd: revenues and profitability

Figure 15: Aspen Pharmacare Holdings Ltd: assets and liabilities

Figure 16: Teva Pharmaceutical Industries Limited: revenues and profitability

Figure 17: Teva Pharmaceutical Industries Limited: assets and liabilities

Description de l'éditeur

About MarketLine

MarketLine, is one of the most prolific publishers of global business information today. Profiling all major companies, industries and geographies, no other business information company comes close to matching our sheer breadth of coverage. Our content is produced by an internal team of analysts, drawing on primary and secondary research and prepared under an established methodology that’s been tried and tested over 10 years. With offices in New York, London, Manchester, Sydney, MarketLine continues to build an enviable clientele list spanning the world within a number of industries and across variety of job functions.

MarketLine coverage includes Company reports, Industry Profiles, Country Profiles and Financial deals activity for companies and industries.

 

Contact:  Partner Supportpartnersupport@globaldata.com

                 Sunil Sethia ssethia@globaldata.com